NurExone Biologic Inc.
NRX.V
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 205.43% | -61.04% | -48.51% | -81.94% | 29.39% |
| Total Receivables | -29.92% | -52.90% | -76.54% | -65.38% | 29.59% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -42.77% | -- | -- | -- | 45.61% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 580.49% | 0.00% | 0.00% | 28.13% | -96.66% |
| Total Current Assets | 59.18% | -59.40% | -29.85% | -62.90% | -17.56% |
|
|
|||||
| Total Current Assets | 59.18% | -59.40% | -29.85% | -62.90% | -17.56% |
| Net Property, Plant & Equipment | 7.06% | 11.50% | 79.33% | 66.88% | 329.26% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 67.27% | -26.78% | -13.00% | -48.33% | 12.49% |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | 103.54% | 112.79% | 90.17% | -19.05% | -38.14% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1,800.00% | -- | -- | -- | -88.89% |
| Total Finance Division Other Current Liabilities | 357.89% | 88.59% | 81.77% | 179.39% | -95.75% |
| Total Other Current Liabilities | 357.89% | 88.59% | 81.77% | 179.39% | -95.75% |
| Total Current Liabilities | 148.49% | 98.16% | 84.43% | 52.76% | -79.14% |
|
|
|||||
| Total Current Liabilities | 148.49% | 98.16% | 84.43% | 52.76% | -79.14% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 125.81% | 154.84% | 264.00% | 29.17% | 1,450.00% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 5.98% | 12.73% | 60.27% | 92.00% | 253.52% |
| Total Liabilities | 94.85% | 73.32% | 85.77% | 61.25% | -65.67% |
|
|
|||||
| Common Stock & APIC | 34.04% | 33.97% | 35.21% | 23.74% | 60.06% |
| Retained Earnings | -33.42% | -37.23% | -38.76% | -38.71% | -35.88% |
| Treasury Stock & Other | 54.12% | -36.16% | -31.59% | -20.44% | -33.06% |
| Total Common Equity | 56.62% | -50.24% | -40.50% | -63.76% | 831.75% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 56.62% | -50.24% | -40.50% | -63.76% | 831.75% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 56.62% | -50.24% | -40.50% | -63.76% | 831.75% |
|
|
|||||